Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
about
Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence
P2860
Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fulvestrant inhibits growth of ...... ancer by up-regulation of ERβ.
@en
Fulvestrant inhibits growth of ...... ancer by up-regulation of ERβ.
@nl
type
label
Fulvestrant inhibits growth of ...... ancer by up-regulation of ERβ.
@en
Fulvestrant inhibits growth of ...... ancer by up-regulation of ERβ.
@nl
prefLabel
Fulvestrant inhibits growth of ...... ancer by up-regulation of ERβ.
@en
Fulvestrant inhibits growth of ...... ancer by up-regulation of ERβ.
@nl
P2860
P356
P1433
P1476
Fulvestrant inhibits growth of ...... cancer by up-regulation of ERβ
@en
P2093
Annelie Abrahamsson
Charlotta Dabrosin
P2860
P304
56876-56888
P356
10.18632/ONCOTARGET.10871
P407
P577
2016-08-01T00:00:00Z